http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Song, Gyeong Ju,Kim, Kyung-Bum,Cho, Jae Yong,Woo, Min Sik,Ahn, Jung Hwan,Eom, Jong Hyuk,Ko, Sung Min,Yang, Chan Ho,Hong, Seong Do,Jeong, Se Yeong,Hwang, Won Seop,Woo, Sang Bum,Jhun, Jeong Pil,Jeon, De Elsevier 2019 APPLIED ENERGY Vol.247 No.-
<P><B>Abstract</B></P> <P>We propose a piezoelectric energy harvesting technology installed in a roadway speed bump. We have installed a module that can charge mobile phones utilizing a speed bump piezoelectric harvester (SBPH), which is easy to apply to roads. A highly integrated module with 40 piezo-generators was fixed and installed at the center of the speed bump. When a medium-sized vehicle passed the module at a speed of 30 km/h, an output voltage of 144 V<SUB>max</SUB>, output current of 45.2 mA<SUB>max</SUB>, and output power of 4086.08 mW<SUB>max</SUB> (6.81 W/m<SUP>2</SUP>) were measured at a load resistance of 2 kΩ. When the vehicle passed over the SBPH nine times, it charged a capacitor (10,000 μF) to provide 6 V for about 200 s, and the charged electrical energy was enough to operate a cellphone. The self-controlled battery charging system via electricity generated by the piezoelectric module could be applied to a speed bump installed on an actual road.</P> <P><B>Highlights</B></P> <P> <UL> <LI> The harvester was installed in common speed bump on an actual road. </LI> <LI> The harvesting module produces 4086.08 mW<SUB>max</SUB> and 6.81 W/m<SUP>2</SUP>. </LI> <LI> The harvester successfully charged a mobile phone without external energy source. </LI> <LI> These technologies can improve self-controlled charging system on actual road. </LI> </UL> </P>
Song, Gyo-Chang,Cho, Kyoung-Suok,Yoo, Do-Sung,Huh, Pil-Woo,Lee, Sang-Bok The Korean Neurosurgical Society 2010 Journal of Korean neurosurgical society Vol.48 No.1
Objective : Craniovertebral junction (CVJ) consists of the occipital bone that surrounds the foramen magnum, the atlas and the axis vertebrae. The mortality and morbidity is high for irreducible CVJ lesion with cervico-medullary compression. In a clinical retrospective study, the authors reviewed clinical and radiographic results of occipitocervical fusion using a various methods in 32 patients with CVJ instability. Methods : Thirty-two CVJ lesions (18 male and 14 female) were treated in our department for 12 years. Instability resulted from trauma (14 cases), rheumatoid arthritis (8 cases), assimilation of atlas (4 cases), tumor (2 cases), basilar invagination (2 cases) and miscellaneous (2 cases). Thirty-two patients were internally fixed with 7 anterior and posterior decompression with occipitocervical fusion, 15 posterior decompression and occipitocervical fusion with wire-rod, 5 C1-2 transarticular screw fixation, and 5 C1 lateral mass-C2 transpedicular screw. Outcome (mean follow-up period, 38 months) was based on clinical and radiographic review. The clinical outcome was assessed by Japanese Orthopedic Association (JOA) score. Results : Nine neurologically intact patients remained same after surgery. Among 23 patients with cervical myelopathy, clinical improvement was noted in 18 cases (78.3%). One patient died 2 months after the surgery because of pneumonia and sepsis. Fusion was achieved in 27 patients (93%) at last follow-up. No patient developed evidence of new, recurrent, or progressive instability. Conclusion : The authors conclude that early occipitocervical fusion to be recommended in case of reducible CVJ lesion and the appropriate decompression and occipitocervical fusion are recommended in case of irreducible craniovertebral junction lesion.
Pil Sang Song,Seok-Woo Seong,Ji-Yeon Kim,Soo Yeon An,Mi Joo Kim,Kye Taek Ahn,Seon-Ah Jin,Jin-Ok Jeong,Jeong Hoon Yang,Joo-Yong Hahn,Hyeon-Cheol Gwon,Woo Jin Jang,Hyuck Jun Yoon,Jang-Whan Bae,Woong Gil 대한심장학회 2024 Korean Circulation Journal Vol.54 No.4
Background and Objectives: Concerns remain that early aspirin cessation may be associated with potential harm in subsets at high risk of ischemic events. This study aimed to assess the effects of P2Y12 inhibitor monotherapy after 3-month dual antiplatelet therapy (DAPT) vs. prolonged DAPT (12-month or longer) based on the ischemic risk stratification, the CHADS-P2A2RC, after percutaneous coronary intervention (PCI). Methods: This was a sub-study of the SMART-CHOICE trial. The effect of the randomized antiplatelet strategies was assessed across 3 CHADS-P2A2RC risk score categories. The primary outcome was a major adverse cardiac and cerebral event (MACCE), a composite of all-cause death, myocardial infarction, or stroke. Results: Up to 3 years, the high CHADS-P2A2RC risk score group had the highest incidence of MACCE (105 [12.1%], adjusted hazard ratio [HR], 2.927; 95% confidence interval [CI], 1.358–6.309; p=0.006) followed by moderate-risk (40 [1.4%], adjusted HR, 1.786; 95% CI, 0.868–3.674; p=0.115) and low-risk (9 [0.5%], reference). In secondary analyses, P2Y12 inhibitor monotherapy reduced the Bleeding Academic Research Consortium (BARC) types 2, 3, or 5 bleeding without increasing the risk of MACCE as compared with prolonged DAPT across the 3 CHADS-P2A2RC risk strata without significant interaction term (interaction p for MACCE=0.705 and interaction p for BARC types 2, 3, or 5 bleeding=0.055). Conclusions: The CHADS-P2A2RC risk score is valuable in discriminating high-ischemic-risk patients. Even in such patients with a high risk of ischemic events, P2Y12 inhibitor monotherapy was associated with a lower incidence of bleeding without increased risk of ischemic events compared with prolonged DAPT.
High-Performance Visible-Blind UV Phototransistors Based on n-Type Naphthalene Diimide Nanomaterials
Song, Inho,Lee, Seung-Chul,Shang, Xiaobo,Ahn, Jaeyong,Jung, Hoon-Joo,Jeong, Chan-Uk,Kim, Sang-Wook,Yoon, Woojin,Yun, Hoseop,Kwon, O-Pil,Oh, Joon Hak American Chemical Society 2018 ACS APPLIED MATERIALS & INTERFACES Vol.10 No.14
<P>This study investigates the performance of single-crystalline nanomaterials of wide-band gap naphthalene diimide (NDI) derivatives with methylene-bridged aromatic side chains. Such materials are found to be easily used as high-performance, visible-blind near-UV light detectors. NDI single-crystalline nanoribbons are assembled using a simple solution-based process (without solvent-inclusion problems), which is then applied to organic phototransistors (OPTs). Such OPTs exhibit excellent n-channel transistor characteristics, including an average electron mobility of 1.7 cm<SUP>2</SUP> V<SUP>-1</SUP> s<SUP>-1</SUP>, sensitive UV detection properties with a detection limit of ∼1 μW cm<SUP>-2</SUP>, millisecond-level responses, and detectivity as high as 10<SUP>15</SUP> Jones, demonstrating the highly sensitive organic visible-blind UV detectors. The high performance of our OPTs originates from the large face-to-face π-π stacking area between the NDI semiconducting cores, which is facilitated by methylene-bridged aromatic side chains. Interestingly, NDI-based nanoribbon OPTs exhibit a distinct visible-blind near-UV detection with an identical detection limit, even under intense visible light illumination (for example, 10<SUP>4</SUP> times higher intensity than UV light intensity). Our findings demonstrate that wide-band gap NDI-based nanomaterials are highly promising for developing high-performance visible-blind UV photodetectors. Such photodetectors could potentially be used for various applications including environmental and health-monitoring systems.</P> [FIG OMISSION]</BR>
Song, Pil Sang,Ryu, Dong Ryeol,Kim, Min Jeong,Jeon, Ki-Hyun,Choi, Rak Kyeong,Park, Jin Sik,Song, Young Bin,Hahn, Joo-Yong,Gwon, Hyeon-Cheol,Ahn, Youngkeun,Jeong, Myung Ho,Choi, Seung-Hyuk The Korean Society of Cardiology 2018 Korean Circulation Journal Vol.48 No.6
<P><B>Background and Objectives</B></P><P>A risk prediction is needed even in the contemporary era of acute myocardial infarction (AMI). We sought to develop a risk scoring specific for patients with AMI being treated with guideline-adherent optimal therapies, including percutaneous coronary intervention and all 5 medications (aspirin, thienopyridine, β-blocker, angiotensin-converting enzyme inhibitor or angiotensin receptor blocker, and statin).</P><P><B>Methods</B></P><P>From registries, 12,174 AMI patients were evaluated. The primary outcome was 1-year all-cause death or AMI. The Korea Working Group in Myocardial Infarction (KorMI) system was compared with the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI), Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC), and Global Registry of Acute Coronary Events scores (GRACE) models.</P><P><B>Results</B></P><P>Ten predictors were identified: left ventricular dysfunction (hazard ratio [HR], 2.3), bare-metal stent (HR, 2.0), Killip class ≥II (HR, 1.9), renal insufficiency (HR, 1.8), previous stroke (HR, 1.6), regional wall-motion- score >20 on echocardiography (HR, 1.5), body mass index ≤24 kg/m<SUP>2</SUP> (HR, 1.4), age ≥70 years (HR, 1.4), prior coronary heart disease (HR, 1.4), and diabetes (HR, 1.4). Compared with the previous models, the KorMI system had good discrimination (time-dependent C statistic, 0.759) and showed reasonable goodness-of-fit by Hosmer-Lemeshow test (p=0.84). Moreover, the continuous-net reclassification improvement varied from −27.3% to −19.1%, the integrated discrimination index varied from −2.1% to −0.9%, and the median improvement in risk score was from −1.0% to −0.4%.</P><P><B>Conclusions</B></P><P>The KorMI system would be a useful tool for predicting outcomes in survivors treated with guideline-adherent optimal therapies after AMI.</P>
( Pil Soo Sung ),( Dong Jin Yoon ),( Do Seon Song ),( Jung Hyun Kwon ),( Soon Woo Nam ),( Jeong Won Jang ),( Jong Young Choi ),( Seung Kew Yoon ),( Seok Whan Moon ),( Hong Seok Jang ),( Si Hyun Bae ) 대한간학회 2018 춘·추계 학술대회 (KASL) Vol.2018 No.1
Aims: We performed a retrospective study to identify prognostic factors and determine outcomes for patients with brain metastases from hepatocellular carcinoma (HCC). Methods: A total of 72 patients with brain metastases from HCC were identified from two institutions; 26 of 72 patients received tumor-removing surgery or stereotactic radiosurgery with or without whole-brain radiotherapy (WBRT), 23 of 72 received WBRT only, and 23 of 72 received conservative treatment. Estimates for overall survival (OS) after brain metastases were determined and clinical prognostic factors were identified by Cox proportional hazards modeling. Results: Median OS after development of brain metastases was 48 days (one day to 536 days). The median age at the time patients were diagnosed with brain metastasis was 54 years. Fifty-one patients (71%) were male, and 62 patients (86%) were infected with hepatitis B virus. Median time from diagnosis of HCC to brain metastasis was 17.2 months, and 4 patients had brain metastases at the time diagnosis. Intracranial hemorrhage was frequently associated (42%) with brain metastasis. The most common presenting symptoms were motor weakness, mental change, and headache. Sixty-three patients (88%) had lung metastases, 25 patients (35%) had bone metastases, 18 patients (25%) had metastatic lymphadenopathy, and 7 (10%) patients had peritoneal seeding when diagnosed with brain involvement, and there was only one patient without metastasis to other organs. Univariate analyses showed that treatment with curative intent (surgery or SRS) and serum AFP levels were associated with improved survival (P<0.001, and 0.045, respectively), whereas a single brain metastasis, size of metastatic tumor, or intracranial hemorrhage were not. We further divided patients with three groups by the treatment modality; surgery or radiosurgery (group1), WBRT (group 2), or conservative treatment (group 3). Group 1 showed best survival, followed by group 2 and group 3, sequentially (P<0.001). Subgroup analysis with patients with single brain metastasis showed similar results. Multivariate analysis showed that treatment modality was the only factor that is associated with improved OS (P=0.001) Conclusions: When patients with lung metastases from HCC present neurologic symptoms, brain imaging is required to confirm intracranial metastases. Although the overall prognosis of patients with brain metastases from HCC is extremely poor, patients actively treated with surgery or radiosurgery have prolonged survival, suggesting that interventions to control intracranial disease are important treatment modalities.
Song, Mi-Young,Kim, Sang Hoon,Ryoo, Ga-Hee,Kim, Mi-Kyung,Cha, Hye-Na,Park, So-Young,Hwang, Hong Pil,Yu, Hee Chul,Bae, Eun Ju,Park, Byung-Hyun Nature Publishing Group UK 2019 Experimental and molecular medicine Vol.51 No.5
<▼1><P>Adipose tissue inflammation is a reproducible feature of obesity and obesity-linked insulin resistance. Although sirtuin 6 (Sirt6) deficiency has previously been implicated in diet-induced obesity and systemic insulin resistance, the adipocyte-specific role of Sirt6 in the regulation of adipose tissue inflammation and systemic metabolic dysfunction in mice fed normal chow and in humans remains elusive. Here, using <I>Adipoq-Cre</I>-mediated adipocyte-specific Sirt6 knockout (aS6KO) mice, we explored whether adipocyte Sirt6 inhibits adipose tissue inflammation and its underlying mechanism. aS6KO mice fed normal chow gained more body weight and fat mass than wild-type mice and exhibited glucose intolerance and systemic insulin resistance. Measurement of plasma and tissue cytokines and flow cytometric analysis of adipose stromal vascular cells indicated a decrease in alternatively activated M2 macrophages in the adipose tissue of aS6KO mice. Mechanistically, Sirt6 regulated the expression of the canonical type 2 cytokine IL-4 by adipocytes in a cell autonomous manner, which in turn affects M2 macrophage polarization. Consistent with animal experimental data, the degree of obesity and insulin resistance demonstrated by the body mass index, fasting blood glucose and HbA1c correlated negatively with the expression of Sirt6 in human visceral fat tissues. Collectively, these results suggest that adipocyte Sirt6 regulates body weight gain and insulin sensitivity independent of diet, and the increased IL-4 production by Sirt6 and resultant M2 polarization of adipose tissue macrophages may attenuate proinflammatory responses in adipose tissue.</P></▼1><▼2><P><B>Obesity and diabetes: A control protein in fat</B></P><P>A protein in adipose tissue (composed of fat cells) helps protect against inflammation and the development of resistance to insulin that develops in obesity and can lead to type 2 diabetes. Researchers in South Korea, led by Eun Ju Bae at Woosuk University, Wanju, and Byung-Hyun Park at Chonbuk National University, Jeonju, investigated the role of Sirt6 in mice and in human adipose tissue. Deleting the mouse gene that codes for Sirt6 in adipocytes promoted the impaired response to insulin and associated increase in blood glucose levels that are two key aspects of diabetes. Changes in biochemical signaling pathways controlling immune cells called macrophages were implicated in these effects and suggest an anti-inflammatory role for Sirt6. Analysis of human adipose tissue supported these findings. The research will help understand how obesity promotes type 2 diabetes.</P></▼2>